Drug intelligence / Profile preview

11C-5-hydroxytryptophan

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

C-5-hydroxytryptophan (11C-5-HTP)** is a radiolabeled form of the amino acid precursor to serotonin, used primarily as a positron emission tomography (PET) imaging agent. The compound consists of 5-hydroxy-L-tryptophan labeled with the radioactive isotope carbon‑11. It is utilized in PET scans to study serotonin synthesis and turnover in the brain and to assess neuroendocrine tumors or pancreatic endocrine function. In research settings, uptake and utilization of tracer amounts of [beta‑11C]5‑HTP have been used as markers for regional serotonin formation and β-cell function in the pancreas[7][10]. The mechanism involves its uptake by cells that synthesize serotonin or related amines; after crossing cell membranes, it is decarboxylated to radiolabeled serotonin or other metabolites that can be imaged by PET[7][10]. This allows for noninvasive quantification of serotonergic activity or endocrine cell mass.

Other names
11C-5-hydroxytryptophancarbon-11 labeled 5-hydroxytryptophancarbon11 labeled 5-hydroxytryptophancarbon 11 labeled 5-hydroxytryptophan
02

Targets

DDC (Aromatic L-amino acid decarboxylase)SLC7A5 (Large neutral amino acid transporter small subunit 1)

Beyond the preview

Go deeper on 11C-5-hydroxytryptophan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-5-hydroxytryptophan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call